Medtronic (MDT) balance sheet and financial health
TrendArc score 59 of 100 · Health 6.8 · Momentum 8.6 · Moat 6.1 · scored Nov 17, 2026 · How the score works
Cash and short-term investments less borrowings, April 24, 2026
$18.7 billion more borrowings than cash
Medtronic held $9.2 billion of cash and short-term investments against $27.9 billion of borrowings on April 24, 2026. Its lease liabilities, shown apart from borrowings, were $1.2 billion. In the fiscal year to April 2026 its operating income covered its interest 9.0 times.
Borrowings to equity
0.56
$27.9B of borrowings on $49.5B of equity, Apr 2026
Interest cover
9.0x
operating income over interest, fiscal year to April 2026
Return on invested capital
7.8%
latest quarter to July 2026, annualised; the stock card's measure
Cash and borrowings at each fiscal year end
What the balance sheet holdsApril 24, 2026
"Other liabilities" is total liabilities less borrowings and lease liabilities; "Property, goodwill and other" is total assets less the current assets and long-term investments; "Minority interests and other" is the rest of the funding (total assets less liabilities and shareholders' equity), mostly outside owners' stakes in subsidiaries.
Balance sheet, the last 10 fiscal year ends
| Fiscal year end | Apr 2026 | Apr 2025 | Apr 2024 | Apr 2023 | Apr 2022 | Apr 2021 | Apr 2020 | Apr 2019 | Apr 2018 | Apr 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Cash and short-term investments | 9.2 | 9.0 | 8.0 | 8.0 | 10.6 | 10.8 | 10.9 | 9.8 | 11.2 | 13.7 |
| Receivables | 6.6 | 6.5 | 6.1 | 6.0 | 5.6 | 5.5 | 4.6 | 6.2 | 6.0 | 5.6 |
| Inventory | 6.0 | 5.5 | 5.2 | 5.3 | 4.6 | 4.3 | 4.2 | 3.8 | 3.6 | 3.3 |
| Other current assets | 3.0 | 2.9 | 2.6 | 2.4 | 2.3 | 2.0 | 2.2 | 2.1 | 2.2 | 2.2 |
| Total current assets | 24.8 | 23.8 | 21.9 | 21.7 | 23.1 | 22.5 | 22.0 | 22.0 | 23.0 | 24.9 |
| Long-term investments | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Total assets | 93.0 | 91.7 | 90.0 | 90.9 | 91.0 | 93.1 | 90.7 | 89.7 | 91.4 | 99.9 |
| Liabilities and equity | ||||||||||
| Current liabilities | 11.7 | 12.9 | 10.8 | 9.1 | 12.4 | 8.5 | 10.4 | 8.5 | 10.1 | 14.3 |
| Borrowings | 27.9 | 28.5 | 25.0 | 24.3 | 24.1 | 26.3 | 24.7 | 25.3 | 25.8 | 33.4 |
| Lease liabilities | 1.2 | 1.2 | 1.1 | 1.1 | 0.9 | 1.1 | 1.0 | — | — | — |
| Total liabilities | 43.0 | 43.4 | 39.6 | 39.3 | 38.3 | 41.5 | 39.8 | 39.5 | 40.6 | 49.5 |
| Minority interests and other | 0.6 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Shareholders' equity | 49.5 | 48.0 | 50.2 | 51.5 | 52.6 | 51.4 | 50.7 | 50.1 | 50.7 | 50.2 |
| Financial health | ||||||||||
| Cash less borrowings | -18.7 | -19.5 | -17.0 | -16.3 | -13.5 | -15.5 | -13.8 | -15.5 | -14.5 | -19.7 |
| Borrowings to equity | 0.56 | 0.59 | 0.50 | 0.47 | 0.46 | 0.51 | 0.49 | 0.51 | 0.51 | 0.67 |
| Interest cover | 9.0x | 8.2x | 7.2x | 8.6x | 10.4x | 4.8x | 4.4x | 4.3x | 5.8x | 4.9x |
Interest cover is operating income over interest expense, for full fiscal years. Minority interests and other is total assets less total liabilities and shareholders' equity (calculated by TrendArc). Company filings as standardised by Tiingo; borrowings and lease liabilities told apart with the lines the company files on SEC EDGAR, and a dash where the two cannot be told apart. Rebuilt nightly.
Medtronic against its peers
| Company | Cash less borrowings | Borrowings to equity | Interest cover | Return on invested capital |
|---|---|---|---|---|
| Edwards LifesciencesEW | +$4.05B | 0.06 | 54.2x | 10.7% |
| Idexx LaboratoriesIDXX | -$651M | 0.45 | 35.0x | 56.0% |
| GE HealthCareGEHC | -$7.12B | 0.86 | 6.3x | 11.4% |
| Boston ScientificBSX | -$11.3B | 0.47 | 10.3x | 6.4% |
| StrykerSYK | -$11.7B | 0.64 | 8.1x | 8.0% |
| Becton DickinsonBDX | -$15.9B | 0.69 | 4.2x | 4.0% |
| MedtronicMDT | -$18.7B | 0.56 | 9.0x | 7.8% |
| Abbott LaboratoriesABT | -$26.9B | 0.60 | 16.3x | 4.5% |
Each company's newest balance sheet; borrowings leave lease liabilities out; interest cover for its newest fiscal year; return on invested capital is the stock card's measure. A dash where a measure does not apply.
Next
Follow Medtronic with a free account.
A watchlist, price alerts and saved chart layouts. No card needed.
Sign up freeNo forecast, no recommendation. This page describes Medtronic from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Nov 17, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.
The TrendArc score, from 0 to 100, combines three pillars measured from published data, Health (business quality over the last twelve months), Momentum (the price against its moving averages, its 52-week high and the market) and Moat (durability over five years), with the share price's long-run trend. It describes the company as it stands today. It is not a forecast or a recommendation.